Home » WARNER CHILCOTT ANNOUNCES RECEIPT OF PARAGRAPH IV CERTIFICATION NOTICE
WARNER CHILCOTT ANNOUNCES RECEIPT OF PARAGRAPH IV CERTIFICATION NOTICE
Warner Chilcott Company, Inc. announced today that it has received a Paragraph IV Certification Notice from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of LOESTRIN(R) 24 FE.
Drug
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May